找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Early Gastrointestinal Cancers II: Rectal Cancer; Florian Otto,Manfred P. Lutz Book 2014 Springer International Publishing Switzerland 201

[复制链接]
楼主: Definite
发表于 2025-3-28 18:19:25 | 显示全部楼层
https://doi.org/10.1007/978-3-662-33071-5 was probably more efficient (in terms of ypCR) than short course (25/5), and (4) capecitabine was as efficient as 5 FU but oxaliplatin was not adding benefit. Overall, the gains of nCRT remain modest and it is mainly a reduction in local relapse not exceeding 5 %, but no benefit in survival and nei
发表于 2025-3-28 20:55:52 | 显示全部楼层
https://doi.org/10.1007/978-3-662-32623-7e response (pCR) rate was about 10 % higher in the delayed-surgery group. There were no differences in sphincter preservation and R0 resection rate between the two groups. Small studies suggest no differences in the oncological outcomes. Regarding elderly patients who were unfit for chemotherapy, sh
发表于 2025-3-29 00:23:26 | 显示全部楼层
https://doi.org/10.1007/978-3-662-33291-7h treatment regimens. While there is hardly an increase in early toxicity after preoperative SCRT with immediate surgery, late toxicity is substantial compared to surgery alone. Early toxicity is more frequent when a longer interval between SCRT and surgery is used and is comparable to the toxicity
发表于 2025-3-29 06:30:01 | 显示全部楼层
发表于 2025-3-29 07:58:37 | 显示全部楼层
Total Mesorectal Excision: Open, Laparoscopic or Roboticerative outcomes and similar oncologic results. However, the conversion rate of LTME is around 17 %. The literature supporting RTME is more limited. Robotic rectal resection appears to have similar postoperative and oncologic outcomes compared to LTME. RTME results in higher costs and possibly lower
发表于 2025-3-29 12:29:47 | 显示全部楼层
发表于 2025-3-29 17:22:09 | 显示全部楼层
Quality of Life After Surgery for Rectal Canceroadjuvant therapy (50 %). The most frequently used instruments were the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (QLQ-C30), its colorectal cancer specific module QLQ-CR38, and the Medical Outcomes Study Short-Form 36 items questionnaire. Findin
发表于 2025-3-29 21:08:27 | 显示全部楼层
发表于 2025-3-30 03:26:34 | 显示全部楼层
发表于 2025-3-30 05:36:56 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-22 14:04
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表